BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1095502)

  • 1. Aminopenicillins - clinical pharmacology and use in disease states.
    Neu HC
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):132-44. PubMed ID: 1095502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aminopenicillin: when, how, what kind?].
    Mombelli G
    Schweiz Med Wochenschr; 1981 May; 111(18):641-5. PubMed ID: 7244588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative randomized double-blind clinical trial of pivampicillin and ampicillin in lower respiratory tract infections.
    Dewan J; Malik SK; Jindal SK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):85-7. PubMed ID: 7037662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment: drugs five years later. Amoxicillin.
    Neu HC
    Ann Intern Med; 1979 Mar; 90(3):356-60. PubMed ID: 34342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New penicillins in the treatment of urinary tract infection.
    Geedes AM; McGhie D; Hutchison JG; Mahood CB
    Kidney Int Suppl; 1975 Aug; 4():S134-7. PubMed ID: 811918
    [No Abstract]   [Full Text] [Related]  

  • 6. Ampicillin.
    Med Lett Drugs Ther; 1967 Oct; 9(20):78-80. PubMed ID: 6059495
    [No Abstract]   [Full Text] [Related]  

  • 7. The "new" ampicillins: who needs them? Committee on Infectious Diseases and Immunization, Canadian Paediatric Society.
    Can Med Assoc J; 1984 Nov; 131(10):1223-4. PubMed ID: 6498672
    [No Abstract]   [Full Text] [Related]  

  • 8. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral Pivampicillin in pediatric practice (author's transl)].
    Ferrier PE; Diez C
    Schweiz Rundsch Med Prax; 1974 Dec; 63(48):1446-9. PubMed ID: 4438265
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance of two ampicillin esters: a comparison of pivampicillin and bacampicillin.
    Hjort N; Renmarker K; Rosberg B; Skog PA; Hey H
    Pharmatherapeutica; 1983; 3(6):398-404. PubMed ID: 6353431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
    Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
    Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ampicillin and pivampicillin in the treatment of urinary tract infection in children.
    Moe OJ; Meberg A; Eng J
    Scand J Infect Dis; 1977; 9(1):31-6. PubMed ID: 320654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ampicillin.
    Bear DM; Turck M; Petersdorf RG
    Med Clin North Am; 1970 Sep; 54(5):1145-59. PubMed ID: 4248662
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of cyclacillin and ampicillin in urinary tract infections. A double-blind study.
    Henri A; Klastersky J
    Chemotherapy; 1974; 20(2):102-12. PubMed ID: 4367636
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and microbiological evaluation of pivampicillin in the treatment of urinary tract infections.
    Peromet M; Schoutens E; Yourassowsky E
    Curr Ther Res Clin Exp; 1974 Mar; 16(3):201-6. PubMed ID: 4206726
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmakokinetic and clinical studies with azlocillin in paediatrics (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Klin Padiatr; 1980 Sep; 192(5):419-29. PubMed ID: 7192337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of ampicillin in antibiotic therapy with special reference to laboratory findings].
    Legler F
    Arzneimittelforschung; 1966 Jul; 16(7):814-8. PubMed ID: 4870009
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hetacillin.
    Med Lett Drugs Ther; 1971 Jun; 13(12):49-50. PubMed ID: 5559310
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ
    CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.